Here are seven gastroenterology drugs and technologies that have been approved or cleared by the FDA in the past five months: 1. Voquezna Triple Pak and Voquezna Dual Pak, which both treat ...

Nanoparticles enhance drug solubility, stability, and bioavailability, improving therapeutic outcomes for GI conditions like IBD through targeted delivery mechanisms. Hydrogel-based systems offer ...

Please provide your email address to receive an email when new articles are posted on . There were several important FDA approvals for GI conditions over the past year, including the first treatment ...

Scientists headed by a team at the University of British Columbia (UBC) have developed a new approach to drug design that can deliver therapeutics directly to a specific part of the gastrointestinal ...

NEW YORK (Reuters Health) - A drug from the class of antidepressants called selective serotonin reuptake inhibitors (SSRIs), such as Prozac, Zoloft or Paxil, added to a nonsteroidal anti-inflammatory ...

Australian researchers found that a neuropeptide fueled tumor growth in vitro, but deletion of its receptor halted the ...

A rise in popularity in glucagon-like peptide 1 receptor agonists such as Ozempic and Wegovy is causing concern in the medical community over potential side effects for various physician specialties, ...

GLP-1 RAs are not linked to an increased risk for serious GI or hepatobiliary outcomes, compared with other diabetes medications.

Among the most recently approved drugs for weight management, glucagon-like peptide 1 (GLP-1) agonists have garnered considerable attention; however, the effects of these drugs on the gastrointestinal ...

To avoid potentially life-threatening drug-drug interactions in patients with gastrointestinal cancers, clinicians should avoid polypharmacy, but if that is not possible, they should be on the lookout ...